Abstract
Repeated amphetamine administration produced behavioral sensitization to subsequent amphetamine challenge. The development of sensitization was blocked by coadministration of the N-methyl-d-aspartate (NMDA) antagonist MK-801. Conditioned locomotion, as revealed by saline challenge, was also blocked by MK-801, suggesting that behavioral sensitization and conditioned locomotion may share a requirement for NMDA receptor stimulation. Repeated MK-801 administration produced behavioral sensitization to MK-801 but not amphetamine challenge, suggesting that MK-801 itself produces sensitization through a different mechanism than amphetamine.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 164-168 |
| Number of pages | 5 |
| Journal | Brain Research |
| Volume | 562 |
| Issue number | 1 |
| DOIs | |
| State | Published - Oct 18 1991 |
| Externally published | Yes |
Funding
We are grateful to Dr. Francis J. White for advice on experimental design and for helpful discussions. Supported by the National Alliance for Research on Schizophrenia and Depression and the Pharmaceutical Manufacturers Association Foundation.
| Funders |
|---|
| Pharmaceutical Research and Manufacturers of America Foundation |
Keywords
- Amphetamine
- Glutamate
- Locomotion
- MK-801
- N-Methyl-d-aspartate
- Sensitization
ASJC Scopus subject areas
- General Neuroscience
- Molecular Biology
- Clinical Neurology
- Developmental Biology
Fingerprint
Dive into the research topics of 'Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS